hims & hers fda warning letter compounded semaglutide 2025 September 15, 2025: Telehealth company must stop implying its GLP-1 is FDA-approved, warns – Partnership for Safe Medicines U.S. FDA sends drug advertising

Bimagrumab leads to increased muscle mass and muscle function, and may also further help with weight loss

Risks & Guidelines Your First 3 Months on Semaglutide: How Much Weight Can You Lose with Ozempic

Safety, Side Effects, and Regulatory Considerations GLP-1 medications are generally considered safe when prescribed appropriately and monitored by a healthcare provider

This establishes a direct neuroendocrine bridge between oral GLP-1 signaling and the central components of the GBA, where it converges with intestinal GLP-1-mediated pathways to regulate appetite and reward processing (58, 61, 168, 169)

Always consult with your healthcare professional before starting any new medication, even over-the-counter options, to ensure its the right fit for your situation

Browse all Peptides & GLP-1 education Retatrutide is an investigational triple agonist that engages the GLP-1, GIP, and glucagon receptors